Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02616705 · ClinicalTrials.gov registry record
Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 511
- Enrollment target
NCT02616705: Completed study, sponsored by Mayo Clinic.
NCT02616705 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 511 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02616705 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 511 participants
- Enrollment target
Study Summary
Immunoglobulin G4-related disease (IgG4-RD) is an uncommon inflammatory disorder that may affect multiple organ systems, including the biliary tree. IgG4-sclerosing cholangitis (IgG4-SC) can be difficult to distinguish from primary sclerosing cholangitis (PSC) or cholangiocarcinoma (CCA). The investigators aim to evaluate the sensitivity and specificity of bile for the diagnosis of IgG4-SC. Bile samples of patients with biliary strictures of various causes, including IgG4-SC, PSC, and CCA, will be collected during clinical cholangiography procedures. IgG4 will be measured in bile specimens and bile IgG4 concentrations compared between IgG4-SC, PSC, CCA, and other types of biliary strictures.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 511 participants |
| Start Date | 2015-11 |
| Est. Completion | 2019-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02616705
The ClinicalTrials.gov registry entry for NCT02616705 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 511 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02616705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02616705 about?
NCT02616705 is a clinical study titled "Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis". Immunoglobulin G4-related disease (IgG4-RD) is an uncommon inflammatory disorder that may affect multiple organ systems, including the biliary tree. IgG4-sclerosing cholangitis (IgG4-SC) can be difficult to distinguish from primary sclerosing cholangitis (PSC) or cholangiocarcinoma (CCA). The invest...
What is the current status of trial NCT02616705?
This trial is currently completed. The enrollment target is 511 participants. The study started on 2015-11. Estimated completion is 2019-09-30.
Who is sponsoring clinical trial NCT02616705?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.